SI
Sofinnova Investments Portfolio holdings
AUM
$2.32B
1-Year Est. Return
101.65%
This Fund
S&P 500
1 Year Est. Return
+101.65%
AUM
$1.63B
AUM Growth
+$160M
(+11%)
Holding
67
Top Buys
| 1 | +$49.3M | |
| 2 | +$40.1M | |
| 3 | +$33.8M | |
| 4 |
Glaukos
GKOS
|
+$28.7M |
| 5 |
United Therapeutics
UTHR
|
+$24.3M |
Top Sells
| 1 | +$75.6M | |
| 2 | +$31.5M | |
| 3 | +$29.6M | |
| 4 |
uniQure
QURE
|
+$25.8M |
| 5 |
Insmed
INSM
|
+$25.7M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Pharvaris
PHVS
$1.68B
| $18.5M | 1.13% |
739,876
+154,344
|
|
||
27
Supernus Pharmaceuticals
SUPN
$3.08B
| $18M | 1.11% |
377,066
-422,187
|
|
||
28
Arcus Biosciences
RCUS
$3.08B
| $16.6M | 1.02% |
1,222,263
+6,247
|
|
||
|
MRUS
29
DELISTED
Merus
MRUS
| $15.7M | 0.96% |
166,729
-237,833
|
|
||
|
30
Insmed
INSM
$31B
| $15M | 0.92% |
104,339
-209,584
|
|
||
31
Inhibrx
INBX
$1.04B
| $14.8M | 0.91% |
440,092
-268,586
|
|
||
|
BIOA
32
BioAge Labs
BIOA
$876M
| $13.5M | 0.83% |
2,293,788
-11,113
|
|
||
33
Celcuity
CELC
$5.42B
| $12.5M | 0.77% |
+253,375
|
|
||
34
Dyne Therapeutics
DYN
$3.26B
| $12.5M | 0.77% |
985,828
+370,963
|
|
||
35
PTC Therapeutics
PTCT
$5.68B
| $11.5M | 0.7% |
186,932
-189,007
|
|
||
36
GE HealthCare
GEHC
$33.1B
| $11.3M | 0.7% |
+151,085
|
|
||
37
Soleno Therapeutics
SLNO
$2.18B
| $11.2M | 0.69% |
166,281
-248,938
|
|
||
38
Praxis Precision Medicines
PRAX
$8.63B
| $9.16M | 0.56% |
172,833
+157,116
|
|
||
39
Savara
SVRA
$1.14B
| $8.67M | 0.53% |
2,427,724
-29,628
|
|
||
40
Edgewise Therapeutics
EWTX
$3.14B
| $8.44M | 0.52% |
520,240
-196,633
|
|
||
|
41
uniQure
QURE
$1.14B
| $7.99M | 0.49% |
136,862
-1,421,494
|
|
||
42
AnaptysBio
ANAB
$1.72B
| $7.79M | 0.48% |
254,268
-778,094
|
|
||
43
Compass Therapeutics
CMPX
$991M
| $7.1M | 0.44% |
+2,028,886
|
|
||
44
Nektar Therapeutics
NKTR
$2.02B
| $6.74M | 0.41% |
+118,419
|
|
||
|
CDTX
45
DELISTED
Cidara Therapeutics
CDTX
| $5.19M | 0.32% |
54,197
-196,834
|
|
||
46
Immunome
IMNM
$2.41B
| $5.11M | 0.31% |
436,051
-342,425
|
|
||
47
NextCure
NXTC
$44.6M
| $1.3M | 0.08% |
222,654
-1
|
|
||
48
Wave Life Sciences
WVE
$2.59B
| $1.25M | 0.08% |
170,943
+53,040
|
|
||
49
Scholar Rock
SRRK
$4.57B
| $1.17M | 0.07% |
31,410
+4,970
|
|
||
|
JBIO
50
Jade Biosciences
JBIO
$714M
| $927K | 0.06% |
107,391
|
|